We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
The U.S. Food and Drug Administration announced this week it has authorized the marketing of three new tobacco products, CNN reports. R.J. Reynolds will be allowed to sell three of its Vuse vape products.
A new study finds 20% of surgical patients who start taking prescription opioids after their procedure continue to take them three months after surgery.
College students who misuse prescription stimulant medications such as Adderall or Ritalin in an attempt to focus better while studying are at increased risk of misusing other substances including alcohol and marijuana, new research finds.
View our curated digest of the latest research news, including the efficacy of a web-based treatment tool designed to identify substance use treatment centers.
More than 2 million U.S. middle school and high school students say they currently use e-cigarettes, according to a new report by the Centers for Disease Control and Prevention.
The Drug Enforcement Administration has issued a warning about an increase in counterfeit pills laced with fentanyl that are made to look like real prescription medications.
Over the last decade, doctors prescribed 44% fewer opioids, yet opioid overdoses continued to rise, a new report from the American Medical Association finds.
California’s state attorney general has approved signature gathering for a proposed ballot initiative that would decriminalize the psychedelic drug psilocybin, the psychoactive compound found in “magic mushrooms.”
Find more of our must-reads in policy news, including a report from the American Medical Association with new recommendations to address increasing opioid overdose rates.
Opioid overdose deaths increased 38% among non-Hispanic Black Americans from 2018 to 2019, a new study finds. In contrast, opioid overdose deaths remained about the same among other race and ethnicity groups, HealthDay reports.
The Food and Drug Administration announced it was delaying a decision about whether to allow Juul e-cigarettes to stay on the market, the Associated Press reports. The agency said it had rejected applications for almost 950,000 other e-cigarettes and related products, because of their potential to appeal to minors.
Get Support
